Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT02370693Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Mar 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in systemic sclerosis-associated interstitial lung disease (SSc-ILD), sponsored by Northwestern University. Started Mar 2016; status: completed.
02
Drugs
bortezomib
03
Conditions
systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Beyond the preview
Go deeper on NCT02370693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370693.